DE69033728T2 - Impfstoffkonjugat - Google Patents

Impfstoffkonjugat

Info

Publication number
DE69033728T2
DE69033728T2 DE69033728T DE69033728T DE69033728T2 DE 69033728 T2 DE69033728 T2 DE 69033728T2 DE 69033728 T DE69033728 T DE 69033728T DE 69033728 T DE69033728 T DE 69033728T DE 69033728 T2 DE69033728 T2 DE 69033728T2
Authority
DE
Germany
Prior art keywords
virus
vaccine
pharmaceutically acceptable
vnf
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69033728T
Other languages
German (de)
English (en)
Other versions
DE69033728D1 (de
Inventor
Tommy L Fredericksen
Thaxton, Jr
Dr Thoma
Julius K Tyczkowski
Craig E Whitfill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arkansas at Fayetteville
Original Assignee
University of Arkansas at Fayetteville
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arkansas at Fayetteville filed Critical University of Arkansas at Fayetteville
Publication of DE69033728D1 publication Critical patent/DE69033728D1/de
Application granted granted Critical
Publication of DE69033728T2 publication Critical patent/DE69033728T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69033728T 1989-10-02 1990-10-01 Impfstoffkonjugat Expired - Lifetime DE69033728T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41603589A 1989-10-02 1989-10-02
US48067890A 1990-02-15 1990-02-15
US58685990A 1990-09-24 1990-09-24

Publications (2)

Publication Number Publication Date
DE69033728D1 DE69033728D1 (de) 2001-05-31
DE69033728T2 true DE69033728T2 (de) 2001-11-22

Family

ID=27411077

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69033728T Expired - Lifetime DE69033728T2 (de) 1989-10-02 1990-10-01 Impfstoffkonjugat
DE69030383T Expired - Lifetime DE69030383T2 (de) 1989-10-02 1990-10-01 Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69030383T Expired - Lifetime DE69030383T2 (de) 1989-10-02 1990-10-01 Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten

Country Status (11)

Country Link
US (4) US5397569A (enExample)
EP (2) EP0495008B1 (enExample)
AT (2) ATE150976T1 (enExample)
AU (2) AU6714290A (enExample)
BR (1) BR9007702A (enExample)
CA (1) CA2066661C (enExample)
DE (2) DE69033728T2 (enExample)
DK (2) DK0755684T3 (enExample)
ES (2) ES2158200T3 (enExample)
IL (1) IL95867A (enExample)
WO (1) WO1991004749A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA93216B (en) * 1992-01-17 1993-08-18 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant.
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
IL128014A (en) * 1996-09-30 2003-11-23 Univ Arkansas Method of producing active immunity with vaccine conjugate, a vaccine preparation useful for the production of said vaccine conjugate and a process for the manufacture of said vaccine
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
AU779403B2 (en) 1999-08-24 2005-01-20 Teva Pharmaceutical Industries Ltd. A vaccine composition and method of using the same
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US20030170823A1 (en) * 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
EP1161953A3 (en) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV strain for in OVO administration
US7037506B2 (en) 2002-03-08 2006-05-02 Schweltzer Chemical Corporation Ltd. Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
US7029681B2 (en) 2002-03-08 2006-04-18 Schweitzer Chemical Corporation Multiple and multivalent DNA vaccines in ovo
EP1546358A4 (en) 2002-03-22 2006-06-07 Zymogenetics Inc ANTI-IL-TIF ANTIBODIES AND METHOD FOR USE ON INFLAMMATION
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
WO2008147847A1 (en) * 2007-05-22 2008-12-04 Baylor College Of Medicine Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
USRE49477E1 (en) 2012-04-20 2023-03-28 Thomas Jefferson University Engineered antibody for inhibition of fibrosis
US10335484B2 (en) 2013-01-08 2019-07-02 Humabs Biomed Sa Methods of generating robust passive and active immune responses
CN103341164B (zh) * 2013-07-19 2015-06-24 天津瑞普生物技术股份有限公司 一种鸡传染性法氏囊病抗原抗体复合物、制剂及制备方法
CN114616325A (zh) 2019-09-11 2022-06-10 硕腾服务有限责任公司 表达禽病原体抗原的重组火鸡疱疹病毒载体和其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2518978A (en) * 1946-09-12 1950-08-15 American Cyanamid Co Hog cholera vaccine
DE1041214B (de) * 1957-03-11 1958-10-16 Dr Med Karl Theurer Verfahren zur Herstellung von Impfstoffen gegen Viruserkrankungen
US3846543A (en) * 1963-01-02 1974-11-05 Monsanto Co Process for the separation of virus from non-viral proteins
US3326767A (en) * 1966-03-21 1967-06-20 Abbott Lab Avian leukosis treatment with inactivated rous sarcoma virus
US3651213A (en) * 1969-05-29 1972-03-21 Monsanto Co Method for the immunization of a living animal body against viral disease
US3853467A (en) * 1973-08-15 1974-12-10 Gen Electric Method and apparatus for immunological detection of biological particles
CA1039649A (en) * 1973-08-30 1978-10-03 General Electric Company Method of forming multilayer immunologically complexed films
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
EP0073856A1 (en) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
US4493825A (en) * 1982-10-05 1985-01-15 Iowa State University Research Foundation Purified and antigenically selective vaccines for domestic animals
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4614793A (en) * 1983-10-14 1986-09-30 Merck & Co., Inc. Hepatitis A--subunit antigen
US4743562A (en) * 1984-08-21 1988-05-10 The Board Of Trustees Of The Leland Stanford Junior University Purified human cytomegalovirus protein
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US4956452A (en) * 1987-06-14 1990-09-11 The University Of Maryland Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5057314A (en) * 1988-09-30 1991-10-15 Whitfill Craig E Low molecular weight antiviral factors

Also Published As

Publication number Publication date
WO1991004749A1 (en) 1991-04-18
ES2158200T3 (es) 2001-09-01
AU6714290A (en) 1991-04-28
ATE200735T1 (de) 2001-05-15
DE69033728D1 (de) 2001-05-31
AU6755990A (en) 1991-04-28
IL95867A (en) 1994-10-07
EP0495008A1 (en) 1992-07-22
DK0755684T3 (da) 2001-08-20
DE69030383D1 (de) 1997-05-07
US5397569A (en) 1995-03-14
ES2102368T3 (es) 1997-08-01
AU641958B2 (en) 1993-10-07
EP0755684B1 (en) 2001-04-25
US6299874B1 (en) 2001-10-09
BR9007702A (pt) 1992-08-18
CA2066661C (en) 2001-05-08
ATE150976T1 (de) 1997-04-15
US6136319A (en) 2000-10-24
US5871748A (en) 1999-02-16
DK0495008T3 (da) 1997-10-13
EP0495008A4 (en) 1993-05-05
IL95867A0 (enExample) 1991-07-18
DE69030383T2 (de) 1997-10-23
EP0755684A1 (en) 1997-01-29
EP0495008B1 (en) 1997-04-02
CA2066661A1 (en) 1991-04-03

Similar Documents

Publication Publication Date Title
DE69030383T2 (de) Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten
DE68919449T2 (de) Herstellung von IBDV in kontinuierlichen Zellinien.
DE69015222T2 (de) Tocole als Impfstoffadjuvans.
DE68926300T2 (de) Neues virus, verantwortlich für die infektiöse erkrankung der bursa fabricius
DE3882599T2 (de) Hundecoronavirus-Impfstoff.
DE19612967A1 (de) Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
AT402790B (de) Zusammensetzung und verfahren zur prävention und behandlung von entzündungen mit immunglobulin a
DE3685651T2 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
DE3889138T2 (de) Influenza-Impfstoff.
US5397568A (en) Method of treating infectious bursal disease virus infections
DE60019178T2 (de) Neue Antigenklasse von Geflügelreoviren
DE69216732T2 (de) Impfstoff gegen den Geflügelanämieerreger
DE1617940A1 (de) Zellstaemme
DE69835424T2 (de) Boviner atmungs- und darmcoronavirus als impfstoff
DE3854575T2 (de) Reassortantes Rotavirusvakzin.
JP3078013B2 (ja) ワクチン接合体の使用方法、ワクチン調整物および製造品
AT395017B (de) Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates
DE69014974T2 (de) Impfstoff gegen Hundecoronavirus.
DE2949031A1 (de) Vakzine
DE1617756A1 (de) Verfahren zur Herstellung einer neuen Antivirusvaccine
DE60114908T2 (de) Hühner-Anäemie-Virus mit geringer Pathogenität
DE2728802C2 (de) Verfahren zum Herstellen eines antischistosomen immunologischen Mittels
Whitfill et al. Vaccine conjugate for treatment of avian diseases
Whitfill et al. ScholarWorks (DUARK
Whitfill et al. Method of treating viral diseases in animals

Legal Events

Date Code Title Description
8364 No opposition during term of opposition